Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1. Ackerman P, Thompson M, Molina JM, Aberg J, et al. AIDS 2021;35:1061-1072.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Ackerman P, Thompson M, Molina JM, Aberg J, et al. Long-term efficacy and safety of fostemsavir among subgroups of heavily treatment-experienced adults with HIV-1. AIDS 2021;35:1061-1072.
PMID: 33946085